Clinical Trials Browser

Phase 2 × SCLC, Extensive Stage × tislelizumab × Clear all

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Phase 2 Not yet recruiting

SCLC, Extensive Stage